ERS/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases
- PMID: 31699837
- DOI: 10.1183/13993003.01208-2019
ERS/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases
Abstract
This European Respiratory Society/Thoracic Society of Australia and New Zealand statement outlines a review of the literature and expert opinion concerning the management of reproduction and pregnancy in women with airways diseases: asthma, cystic fibrosis (CF) and non-CF bronchiectasis. Many women with these diseases are now living into reproductive age, with some developing moderate-to-severe impairment of lung function in early adulthood. The statement covers aspects of fertility, management during pregnancy, effects of drugs, issues during delivery and the post-partum period, and patients' views about family planning, pregnancy and parenthood. The statement summarises current knowledge and proposes topics for future research, but does not make specific clinical recommendations.
Copyright ©ERS 2020.
Conflict of interest statement
Conflict of interest: P.G. Middleton has nothing to disclose. Conflict of interest: E.J. Gade has nothing to disclose. Conflict of interest: C. Aguilera has nothing to disclose. Conflict of interest: L. Mackillop reports grants from NIHR Oxford Biomedical Research Centre, personal fees from Sensyne Health plc, outside the submitted work; and was a member of the UK's NICE guideline committee for Intrapartum Care for High Risk Women which included a section on women with asthma. Conflict of interest: B.M. Button has nothing to disclose. Conflict of interest: C. Coleman is an employee of the European Lung Foundation. Conflict of interest: B. Johnson is an employee of the European Lung Foundation. Conflict of interest: C. Albrechtsen has nothing to disclose. Conflict of interest: F. Edenborough has nothing to disclose. Conflict of interest: D. Rigau acts a European Respiratory Society methodologist. Conflict of interest: P.G. Gibson reports grants and personal fees from AstraZeneca, GlaxoSmithKline, Novartis and Sanofi, outside the submitted work. Conflict of interest: V. Backer has nothing to disclose.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical